Stay updated on Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Removal of the Melanoma term, the related topics header, and the MedlinePlus Genetics link from the study details page. These changes alter the page’s disease context and access to related educational resources.
    Difference
    0.1%
    Check dated 2026-06-23T23:43:24.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The study page now states that recruitment is closed. It also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment heading along with a Revision: v3.6.0 tag.
    Difference
    0.3%
    Check dated 2026-06-16T19:59:18.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page revision tag was updated from Revision: v3.5.4 to Revision: v3.5.5, indicating a newer patch of the documentation.
    Difference
    0.0%
    Check dated 2026-06-09T15:24:22.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Melanoma condition listing and the MedlinePlus Genetics related topics block were removed. This reduces visible disease context and related educational links on the page.
    Difference
    0.1%
    Check dated 2026-06-01T05:34:53.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Melanoma is added as a related topic and MedlinePlus Genetics is listed as a related resource, and the page revision has been updated from v3.5.3 to v3.5.4.
    Difference
    0.1%
    Check dated 2026-05-18T03:41:18.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page’s UI/version footer was updated from “Revision: v3.5.0” to “Revision: v3.5.3,” reflecting an underlying change to the ClinicalTrials.gov site build rather than any content about the study.
    Difference
    0.0%
    Check dated 2026-04-26T15:48:06.000Z thumbnail image

Stay in the know with updates to Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial page.